Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,775
Recruiting: 1,497
Ph III recruiting: 183
Growth YoY: +6.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,528)

clinicaltrialsPublishedShowing 601–650 of 1,943 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00568490	Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers	recruiting	—	200	Stanford UniversityOTHER	1	Jul 1, 2026	clinicaltrials
NCT04836507	Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients	recruiting	Phase 1 / Phase 2	91	Curocell Inc.INDUSTRY	1	Jul 1, 2026	clinicaltrials